Long-Term Liabilities: The sum of all non-current liabilities.
Climb Bio, Inc. (CLYM) had Long-Term Liabilities of $0.32M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-20.78M |
|
-- |
|
-- |
|
$23.02M |
|
$-23.02M |
|
$2.24M |
|
$-20.78M |
|
$-20.78M |
|
$-20.78M |
|
$-20.78M |
|
$-20.78M |
|
$-20.78M |
|
$-23.02M |
|
$-23.69M |
|
67.46M |
|
67.46M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$100.28M |
|
-- |
|
$100.46M |
|
$200.74M |
|
$7.04M |
|
-- |
|
|
Long-Term Liabilities |
$0.32M |
$7.36M |
|
$193.38M |
|
$193.38M |
|
$193.38M |
|
67.58M |
|
| Cash Flow Statement Financials | |
$-15.43M |
|
$-42.75M |
|
-- |
|
$87.23M |
|
$29.02M |
|
$-58.21M |
|
$2.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.75% |
|
-10.75% |
|
-10.35% |
|
-10.75% |
|
$2.86 |
|
$-0.23 |
|
$-0.23 |
|